Synergistic effects of ionic photosensitizers and silver nanoparticles in PEGDA/gelatin hybrid hydrogels for advanced antibacterial photodynamic therapy
Source abstract
Abstract
Photodynamic therapy offers a promising approach for combating multidrug-resistant bacterial infections. In response to the growing challenge of antibiotic resistance, this study introduces PEGDA/gelatin hybrid hydrogels as smart, multifunctional platforms for photodynamic therapy. These hydrogels were specifically designed to function as both wound dressings and photosensitizer carriers, addressing key clinical needs such as optical transparency, skin-like mechanical properties, moisture management, and controlled release. Toluidine blue O and Eosin Y were effectively released and retained their photodynamic activity under light exposure. Antibacterial testing against Escherichia coli and Staphylococcus aureus revealed that silver nanoparticles alone were insufficient for robust antimicrobial action. However, when combined with photosensitizers, a remarkable enhancement in bacterial inactivation was observed, driven by light-induced synergistic effects. Specifically, the antibacterial efficiency of PEGDA/gelatin hybrid hydrogels containing both Eosin Y and silver nanoparticles increased by 97% against Escherichia coli and 98% against Staphylococcus aureus compared to hydrogels containing Eosin Y alone. This enhancement can be attributed to the anionic nature of Eosin Y, its superior diffusion capacity, and its effective interaction with silver nanoparticles and disrupted bacterial membranes. In contrast, despite the strong photodynamic potential of toluidine blue O, its interaction with silver nanoparticles may have limited its availability for effective microbial targeting. These findings underscore the promise of integrating photosensitizers with silver nanoparticles in a hydrogel matrix to create next-generation wound dressings capable of precise, light-activated antimicrobial action. This approach represents a compelling alternative or supplement to conventional antibiotics. • PEGDA/gelatin hydrogels enable light-activated antibacterial wound therapy. • Hydrogels combined dressing function with photosensitizer delivery and release. • Eosin Y plus silver nanoparticles boosted killing of E. coli and S. aureus . • Synergistic light effects raised Eosin Y hydrogel efficacy by up to 98%. • This platform could complement or reduce reliance on conventional antibiotics.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (75)
Show source-provided references
1. World Health Organization · 2017
2. World Health Organization · 2024
3. Current advances in developing inhibitors of bacterial multidrug efflux pumps10.2174/0929867323666160304150522 ↗
4. Ventola · 2015 · 40 · 277
5. Multidrug resistance in bacteria10.1146/annurev.biochem.78.082907.145923 ↗
6. Access to effective antimicrobials: a worldwide challenge10.1016/S0140-6736(15)00474-2 ↗
7. Antimicrobial photodynamic therapy - what we know and what we don't10.1080/1040841X.2018.1467876 ↗
8. Photodynamic disinfection and its role in controlling infectious diseases10.1007/s43630-021-00102-1 ↗
9. Organic photosensitizers for antimicrobial phototherapy10.1039/D1CS00647A ↗
10. In situ single-cell bacterial imaging provides mechanistic insight into the photodynamic action of photosensitizer-loaded hydrogels10.1021/acsami.3c17916 ↗
11. Photosensitizer-loaded hydrogels for photodynamic inactivation of multirestistant bacteria in wounds10.1039/D0RA09786A ↗
12. New photosensitizers for photodynamic therapy10.1042/BJ20150942 ↗
13. Optimization of hydrogel containing toluidine blue O for photodynamic therapy by response surface methodology10.1016/j.jphotobiol.2017.06.019 ↗
14. Photoinactivation of gram positive and gram negative bacteria with the antimicrobial peptide (KLAKLAK)(2) conjugated to the hydrophilic photosensitizer eosin Y10.1021/bc3005254 ↗
15. Effects of toluidine blue O (TBO)-photodynamic inactivation on community-associated methicillin-resistant Staphylococcus aureus isolates10.1016/j.jmii.2014.12.007 ↗
16. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus10.1128/AAC.49.3.895-902.2005 ↗
17. Increased anti-biofilm efficacy of toluidine blue on Staphylococcus species after nano-encapsulation10.1016/j.pdpdt.2017.12.007 ↗
18. Repeated exposures to blue light-activated eosin Y enhance inactivation of E. faecalis biofilms, in vitro10.1016/j.pdpdt.2015.06.004 ↗
19. ROS conversion promotes the bactericidal efficiency of eosin Y based photodynamic therapy10.1039/D3BM00804E ↗
20. Application of response surface methodology to evaluate photodynamic inactivation mediated by eosin Y and 530 nm LED against Staphylococcus aureus
21. Photodynamic therapy for infected foot ulcers in people with diabetes mellitus: a systematic review10.1590/1516-3180.2022.0476.27022023 ↗
22. Antibacterial photodynamic therapy: overview of a promising approach to fight antibiotic-resistant bacterial infections10.18053/jctres.201503.002 ↗
23. Resistance in antimicrobial photodynamic inactivation of bacteria10.1039/c5pp00037h ↗
24. Current limitations and recent Progress in nanomedicine for clinically available photodynamic therapy10.3390/biomedicines9010085 ↗
25. Photodynamic therapy: photosensitizers and nanostructures10.1039/D0QM00922A ↗
26. Emerging strategies in enhancing singlet oxygen generation of Nano-photosensitizers toward advanced phototherapy
27. Light-Activable silver nanoparticles for combatting antibiotic-resistant Bacteria and biofilms10.3390/molecules30030626 ↗
28. Impact of protein corona and light modulation on the antibacterial activity of light-activated silver nanoparticles10.1039/D5TB00081E ↗
29. ROS-responsive self-activatable photosensitizing agent for photodynamic-immunotherapy of cancer10.1016/j.actbio.2023.03.038 ↗
30. Advances in smart nanotechnology-supported photodynamic therapy for cancer10.1038/s41420-024-02236-4 ↗
31. Hydrogel-based dressings designed to facilitate wound healing10.1039/D3MA00682D ↗
32. Tailoring PEGDA/gelatin hydrogels with silver nanoparticles: mechanical characterization and bacterial inhibition studies10.1016/j.ijbiomac.2025.149996 ↗
33. A study on the material properties of novel PEGDA/gelatin hybrid hydrogels polymerized by electron beam irradiation
34. Study of the influence of structure-chemical properties of Electron beam-polymerized PEGDA/gelatin hybrid hydrogels on the uptake and release dynamics of different photosensitizer molecules10.1021/acs.biomac.4c00982 ↗
35. Polymeric systems as hydrogels and membranes containing silver nanoparticles for biomedical and food applications: recent approaches and perspectives10.3390/gels11090699 ↗
36. Silver nanoparticles: synthesis, properties, and therapeutic applications10.1016/j.drudis.2014.11.014 ↗
37. Understanding the response of poly(ethylene glycol) diacrylate (PEGDA) hydrogel networks: a statistical mechanics-based framework10.1021/acs.macromol.3c02635 ↗
38. Review of gelatin hydrogel dressings based on cross-linking technology in the healing of hemorrhagic wounds: mechanism exploration, application research, and future perspectives10.1002/marc.202500326 ↗
39. The use of photodynamic therapy in medical practice10.3389/fonc.2024.1373263 ↗
40. A new bliss Independence model to analyze drug combination data10.1177/1087057114521867 ↗
41. Evaluation of drug combination effect using a bliss independence dose-response surface model10.1080/19466315.2018.1437071 ↗
42. Comprehensive characterisation of Photocurable PEGDA/Gelatine hydrogels for extrusion-based 3D printing10.3390/gels12020137 ↗
43. Development of a photo-crosslinking, biodegradable GelMA/PEGDA hydrogel for guided bone regeneration materials
44. Injectable and tunable gelatin hydrogels enhance stem cell retention and improve cutaneous wound healing10.1002/adfm.201606619 ↗
45. GelMA/PEGDA microneedles patch loaded with HUVECs-derived exosomes and Tazarotene promote diabetic wound healing10.1186/s12951-022-01354-4 ↗
46. Layered GelMA/PEGDA hydrogel microneedle patch as an intradermal delivery system for hypertrophic scar treatment10.1021/acsami.3c06800 ↗
47. Hydrogel for light delivery in biomedical applications
48. Biocompatible and implantable hydrogel optical waveguide with Lens-microneedles for enhancing light delivery in photodynamic therapy10.1002/adpr.202400031 ↗
49. Mechanical behaviour of skin: A review
50. Synthesis of new thermoplastic elastomers by silver nanoparticles as cross-linker10.1021/ma200738b ↗
51. Preparation of a chitosan/carboxymethyl chitosan/AgNPs polyelectrolyte composite physical hydrogel with self-healing ability, antibacterial properties, and good biosafety simultaneously, and its application as a wound dressing10.1016/j.compositesb.2020.108139 ↗
52. A nano phototheranostic approach of toluidine blue conjugated gold silver core shells mediated photodynamic therapy to treat diabetic foot ulcer10.1038/s41598-021-04008-x ↗
53. Bacterial resistance to antimicrobial photodynamic therapy: a critical update10.1016/j.jphotobiol.2024.112905 ↗
54. Chemical equilibria of eosin Y and its synthetic ester derivatives in non-ionic and ionic micellar environments10.1016/j.molliq.2020.114794 ↗
55. Photodegradation mechanisms and kinetics of eosin-Y in oxic and anoxic conditions10.1016/j.dyepig.2017.06.031 ↗
56. Applications and challenges of photodynamic therapy in the treatment of skin malignancies10.3389/fphar.2024.1476228 ↗
57. Toluidine blue-mediated photodynamic effects on staphylococcal biofilms10.1128/AAC.00988-07 ↗
58. Controlled drug delivery vehicles for cancer treatment and their performance10.1038/s41392-017-0004-3 ↗
59. Nanoparticles in photodynamic therapy10.1021/cr5004198 ↗
60. The immunosuppressive side of PDT10.1039/c0pp00345j ↗
61. Antimicrobial chitosan–PVA hydrogel as a nanoreactor and immobilizing matrix for silver nanoparticles10.1007/s13204-012-0080-1 ↗
62. Cellular impermeability and uptake of biocides and antibiotics in gram-negative bacteria10.1046/j.1365-2672.92.5s1.19.x ↗
63. Photodynamic inactivation of Escherichia coli by curcumin in combination with ε-poly-L-lysine10.1016/j.lwt.2025.117890 ↗
64. Photodynamic therapy: a new antimicrobial approach to infectious disease?10.1039/b311900a ↗
65. Anti-microbial photodynamic therapy: useful in the future?10.1007/s10103-006-0409-7 ↗
66. Uptake pathways of anionic and cationic photosensitizers into bacteria10.1039/b809624d ↗
67. Eosin Y derivatives for visible light-mediated free-radical polymerization: applications in 3D-photoprinting and bacterial photodynamic inactivation10.1016/j.eurpolymj.2024.113143 ↗
68. Localized surface Plasmonic properties of au and ag nanoparticles for sensors: a review10.1007/s11468-021-01381-1 ↗
69. Silver nanoparticles: a versatile tool against infectious and non-infectious diseases
70. Antibacterial activity of silver nanoparticles activated by photodynamic therapy in infected root canals10.17219/dmp/123615 ↗
71. Photosensitizing nanoparticles and the modulation of ROS generation10.3389/fchem.2015.00033 ↗
72. Silver nanoparticle-assisted photodynamic therapy for biofilm eradication10.1021/acsanm.2c01327 ↗
73. Blue laser-activated silver nanoparticles from grape seed extract for photodynamic antimicrobial therapy against Escherichia coli and Staphylococcus aureus10.34172/jlms.2023.69 ↗
74. Synergistic photodynamic antimicrobial therapy with silver nanoparticle activated by UV irradiation and 405 nm laser diode against Escherichia coli and Staphylococcus aureus10.1590/1519-6984.299835 ↗
75. GelMA/PEGDA microneedles patch loaded with HUVECs-derived exosomes and Tazarotene promote diabetic wound healing10.1186/s12951-022-01354-4 ↗